One Three Biotech
Biotechnology, 2 W Loop Rd, New York, 10044, United States, 11-50 Employees
Phone Number: 86********
Who is ONETHREE BIOTECH
OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology drive...
Read More
- Headquarters: 2 W Loop Rd, New York, New York, 10044, United States
- Date Founded: 2018
- Employees: 11-50
- Revenue: Under $1 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834 | NAICS Code: 325412 | Show More
Does something look wrong? Fix it. | View contact records from ONETHREE BIOTECH
OneThree Biotech Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding OneThree Biotech
Answer: OneThree Biotech's headquarters are located at 2 W Loop Rd, New York, 10044, United States
Answer: OneThree Biotech's phone number is 86********
Answer: OneThree Biotech's official website is https://onethree.bio
Answer: OneThree Biotech's revenue is Under $1 Million
Answer: OneThree Biotech's SIC: 2834
Answer: OneThree Biotech's NAICS: 325412
Answer: OneThree Biotech has 11-50 employees
Answer: OneThree Biotech is in Biotechnology
Answer: OneThree Biotech contact info: Phone number: 86******** Website: https://onethree.bio
Answer: OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was built in a lab setting; allowing us to engineer our methodologies around real-world results. While working with major biotech and pharma partners; weve validated our predictions through work in target discovery, compound and combination therapy identification, toxicity prediction, biomarker selection, and much more. Our predictions have been validated with partners such as AstraZeneca, Jubilant, and more. For example, we predicted the top indication, and mechanism of action for Oncoceutics asset ONC201 which was subsequently validated in a Phase II trial.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month